Journal article

Rivastigmine and metabolite analogues with putative Alzheimer's disease-modifying properties in a Caenorhabditis elegans model

Satish N Dighe, Eugenio De la Mora, Stephen Chan, Srinivas Kantham, Gawain McColl, Jared A Miles, Suresh Kumar Veliyath, B Yogi Sreenivas, Zeyad D Nassar, Israel Silman, Joel L Sussman, Martin Weik, Ross P McGeary, Marie-Odile Parat, Xavier Brazzolotto, Benjamin P Ross

Communications Chemistry | NATURE PUBLISHING GROUP | Published : 2019


Awarded by DGA/SSA BioMedef

Funding Acknowledgements

The following financial support is gratefully acknowledged: UQ School of Pharmacy funding (M.-O. P. and B.P.R.); and DGA/SSA BioMedef contract PDH-2 NRBC-3-C-3201 (X. B.). S.N.D., S.C., S.K., J.A.M., S.K.V., B.Y.S. and Z. D.N. thank UQ and the Australian Government for PhD scholarships. S.N.D. thanks UQ for a GSITA travel grant.